105 related articles for article (PubMed ID: 38688280)
1. Mis-splicing of mitotic regulators sensitizes SF3B1-mutated human HSCs to CHK1 inhibition.
Sarchi M; Clough CA; Crosse EI; Kim J; Baquero Galvis LD; Aydinyan N; Wellington R; Yang F; Galli A; Creamer JP; Stewart S; Bradley RK; Malcovati L; Doulatov S
Blood Cancer Discov; 2024 Jun; ():. PubMed ID: 38856693
[TBL] [Abstract][Full Text] [Related]
2. Aberrant RNA Splicing in Cancer.
Escobar-Hoyos L; Knorr K; Abdel-Wahab O
Annu Rev Cancer Biol; 2019 Mar; 3(1):167-185. PubMed ID: 32864546
[TBL] [Abstract][Full Text] [Related]
3. SF3B1 mutant myelodysplastic syndrome: Recent advances.
Pellagatti A; Boultwood J
Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
[TBL] [Abstract][Full Text] [Related]
4. GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies.
Benbarche S; Pineda JMB; Galvis LB; Biswas J; Liu B; Wang E; Zhang Q; Hogg SJ; Lyttle K; Dahi A; Lewis AM; Sarchi M; Rahman J; Fox N; Ai Y; Mehta S; Garippa R; Ortiz-Pacheco J; Li Z; Monetti M; Stanley RF; Doulatov S; Bradley RK; Abdel-Wahab O
Mol Cell; 2024 May; 84(10):1886-1903.e10. PubMed ID: 38688280
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis identifies mutations in
Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R
Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the SF3B1-SUGP1 interface reveals how numerous cancer mutations cause mRNA missplicing.
Zhang J; Xie J; Huang J; Liu X; Xu R; Tholen J; Galej WP; Tong L; Manley JL; Liu Z
Genes Dev; 2023 Dec; 37(21-24):968-983. PubMed ID: 37977822
[TBL] [Abstract][Full Text] [Related]
7. AI-assisted proofreading of RNA splicing.
Guerra-Moreno Á; Valcárcel J
Genes Dev; 2023 Dec; 37(21-24):945-947. PubMed ID: 38092520
[TBL] [Abstract][Full Text] [Related]
8. Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1.
Zhang J; Ali AM; Lieu YK; Liu Z; Gao J; Rabadan R; Raza A; Mukherjee S; Manley JL
Mol Cell; 2019 Oct; 76(1):82-95.e7. PubMed ID: 31474574
[TBL] [Abstract][Full Text] [Related]
9. Splicing quality control mediated by DHX15 and its G-patch activator SUGP1.
Feng Q; Krick K; Chu J; Burge CB
Cell Rep; 2023 Oct; 42(10):113223. PubMed ID: 37805921
[TBL] [Abstract][Full Text] [Related]
10. Targeted high-throughput mutagenesis of the human spliceosome reveals its in vivo operating principles.
Beusch I; Rao B; Studer MK; Luhovska T; Šukytė V; Lei S; Oses-Prieto J; SeGraves E; Burlingame A; Jonas S; Madhani HD
Mol Cell; 2023 Jul; 83(14):2578-2594.e9. PubMed ID: 37402368
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the RNA helicases DDX42 and DDX46 in human U2 snRNP assembly.
Yang F; Bian T; Zhan X; Chen Z; Xing Z; Larsen NA; Zhang X; Shi Y
Nat Commun; 2023 Feb; 14(1):897. PubMed ID: 36797247
[TBL] [Abstract][Full Text] [Related]
12. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer.
Zhang J; Huang J; Xu K; Xing P; Huang Y; Liu Z; Tong L; Manley JL
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2216712119. PubMed ID: 36459648
[No Abstract] [Full Text] [Related]
13. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.
Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y
J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
